ABOUT US

Facility

​

Our secure facility is monitored 24/7.  It has been designed to quickly and accurately execute your clinical project.

Full spectrum temperature controlled storage

Customizable solutions for non-standard storage conditions

Capable of handling cytotoxic, highly potent and DEA Scheduled Materials (Category II-V)

Capable of handling non-traditional clinical supply material including Drug Substance, Intermediates, ADC

Class II Biological Safety Hoods

Redundant systems and back up units

​

Leadership

​

PBLI is lead by Pharma/Biotech Industry veterans who have managed hundreds of clinical projects.

Ed Foster, President

Ed serves as President PBLI with over 30 years of experience in the pharmaceutical, biotechnology, and bio-pharma contract service industries.  Prior to founding PBLI, Mr. Foster served as President (and Founder) of Advantar Laboratories Inc, since 2008 helping to grow the star-up business.  Mr. Foster served as CFO of Apptec Laboratories, Inc from 2006-2008.  He helped transition the business from break even to a company with significant EBITDA margin during his tenure.  He has served in a variety of leadership positions responsible for sales, operations and finance during his 30-year career in companies such as Cardinal Health (now Catalent) and RPR (now Sanofi-Aventis).

Advisor Board

Rich Kenley, PhD

Rich serves as an advisor to PBLI with over 35 years of experience in the pharmaceutical, biotechnology, and biopharma contract service industries.  He is an inventor on 4 patents and author of over 60 peer-reviewed scientific publications.  Dr. Kenley has made major contributions to the development and eventual approval of important pharmaceutical products including: nafarelin (Synarel®), bone morphogenetic protein 2 (InFuse®), rhIL-11 (Neumega®), pramlintide (Symlin®), and exenatide (Byetta®).    He has served in a variety of leadership positions responsible for sales, operations and finance during his 35-year career in companies such as Cardinal Health (now Catalent), Amylin, Genetics Institute, Baxter, Syntex and Stanford Research Institute.

Quality Approach

Our approach to quality systems has been validated over the careers of the leadership team by numerous client and regulatory inspections.

Flexible Approach to Compliance Based on Experience

System tailored to meet needs of customers’ development stage

Training, Qualified Equipment, Written Procedures for GMP

Compliance Master Plan

Systems Approach to Policies and Procedures

Project Director Responsible to customer for all aspects of Project Work